Kala Pharmaceuticals, Inc. (KALA)

USD 3.75

(0.81%)

Total Debt Summary of Kala Pharmaceuticals, Inc.

  • Kala Pharmaceuticals, Inc.'s latest annual total debt in 2023 was 36.32 Million USD , down -15.43% from previous year.
  • Kala Pharmaceuticals, Inc.'s latest quarterly total debt in 2024 Q2 was 36.8 Million USD , up 0.65% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported annual total debt of 42.95 Million USD in 2022, down -46.44% from previous year.
  • Kala Pharmaceuticals, Inc. reported annual total debt of 80.18 Million USD in 2021, down -20.54% from previous year.
  • Kala Pharmaceuticals, Inc. reported quarterly total debt of 36.56 Million USD for 2024 Q1, up 0.66% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported quarterly total debt of 33.56 Million USD for 2023 Q2, up 0.9% from previous quarter.

Annual Total Debt Chart of Kala Pharmaceuticals, Inc. (2023 - 2015)

Historical Annual Total Debt of Kala Pharmaceuticals, Inc. (2023 - 2015)

Year Total Debt Total Debt Growth
2023 36.32 Million USD -15.43%
2022 42.95 Million USD -46.44%
2021 80.18 Million USD -20.54%
2020 100.91 Million USD -0.26%
2019 101.18 Million USD 1.75%
2018 99.44 Million USD 433.08%
2017 18.65 Million USD 93.23%
2016 9.65 Million USD -1.44%
2015 9.79 Million USD 0.0%

Peer Total Debt Comparison of Kala Pharmaceuticals, Inc.

Name Total Debt Total Debt Difference
ANI Pharmaceuticals, Inc. 315.32 Million USD 88.481%
Aquestive Therapeutics, Inc. 98.82 Million USD 63.244%
Collegium Pharmaceutical, Inc. 674.28 Million USD 94.613%
Cosmos Health Inc. 12.42 Million USD -192.363%
Cyclo Therapeutics, Inc. 1.03 Million USD -3415.872%
Esperion Therapeutics, Inc. 540.94 Million USD 93.285%
Cronos Group Inc. 2.53 Million USD -1330.074%
Incannex Healthcare Limited 373 Thousand USD -9638.07%
Lifecore Biomedical, Inc. 130.36 Million USD 72.136%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -60633.693%
Sunshine Biopharma, Inc. 657.7 Thousand USD -5422.689%
Sunshine Biopharma, Inc. 657.7 Thousand USD -5422.689%
SCYNEXIS, Inc. 15.08 Million USD -140.869%
Safety Shot Inc 1.54 Million USD -2244.972%
Theratechnologies Inc. 58.96 Million USD 38.402%
Alpha Teknova, Inc. 30.45 Million USD -19.256%
Universe Pharmaceuticals INC 5.48 Million USD -562.532%
Pacira BioSciences, Inc. 586.04 Million USD 93.802%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD -5874.178%
Dynavax Technologies Corporation 256.91 Million USD 85.862%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 94.924%
Radius Health, Inc. 365.31 Million USD 90.057%
China SXT Pharmaceuticals, Inc. 2.64 Million USD -1271.997%
Alvotech 1.07 Billion USD 96.623%
Intra-Cellular Therapies, Inc. 16.93 Million USD -114.447%
SIGA Technologies, Inc. 1.46 Million USD -2381.064%
Shineco, Inc. 29.65 Million USD -22.479%
Silver Spike Investment Corp. - USD -Infinity%
Journey Medical Corporation 17.73 Million USD -104.867%
Petros Pharmaceuticals, Inc. 8.27 Million USD -338.864%
Embecta Corp. 1.63 Billion USD 97.783%
Harrow Health, Inc. 190.5 Million USD 80.933%
Procaps Group, S.A. 285.93 Million USD 87.297%
Biofrontera Inc. 5.39 Million USD -572.773%
DURECT Corporation 20.74 Million USD -75.084%
PainReform Ltd. 86 Thousand USD -42136.047%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 12.532%
OptiNose, Inc. 131.74 Million USD 72.43%
RedHill Biopharma Ltd. 1.17 Million USD -2996.574%
Organogenesis Holdings Inc. 119.35 Million USD 69.566%
Cumberland Pharmaceuticals Inc. 18.42 Million USD -97.102%
ProPhase Labs, Inc. 21.38 Million USD -69.892%
Phibro Animal Health Corporation 525.45 Million USD 93.087%
Procaps Group S.A. 285.93 Million USD 87.297%
TherapeuticsMD, Inc. 8 Million USD -353.754%
Viatris Inc. 18.12 Billion USD 99.8%
Rockwell Medical, Inc. 13.43 Million USD -170.281%
Aytu BioPharma, Inc. 15.12 Million USD -140.089%
Tilray Brands, Inc. 387.31 Million USD 90.622%
PetIQ, Inc. 468.3 Million USD 92.244%
Talphera, Inc. - USD -Infinity%
Neurocrine Biosciences, Inc. 428.4 Million USD 91.521%
Alimera Sciences, Inc. 67.39 Million USD 46.108%
Assertio Holdings, Inc. 40.91 Million USD 11.217%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD -3239.45%
Avadel Pharmaceuticals plc 35.38 Million USD -2.654%
Hempacco Co., Inc. 13.72 Million USD -164.658%
Alvotech 1.07 Billion USD 96.623%
Lantheus Holdings, Inc. 616.94 Million USD 94.112%
Kamada Ltd. 8.74 Million USD -315.168%
Currenc Group, Inc. 31.94 Million USD -13.71%
Indivior PLC 281.6 Million USD 87.101%
Evoke Pharma, Inc. 5 Million USD -626.46%
Flora Growth Corp. 3.67 Million USD -889.188%
Cyclo Therapeutics, Inc. 1.03 Million USD -3415.872%
Evolus, Inc. 126.54 Million USD 71.297%
HUTCHMED (China) Limited 86.13 Million USD 57.828%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 94.176%
Akanda Corp. 3.99 Million USD -808.35%